Institute of Pharmacology and Toxicology Academy of Military Medical Sciences Pla China

Beijing Molecule Science and Technology Co., Ltd.

Chinese Pla General Hospital

Institute of Pharmacology and Toxicology Academy of Military Medical Science P.l.a. China

Peking University

Academy of Military Medical Sciences

Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.l.a.

Institute of Pharmacology and Toxicology Medical Sciences P.l.a. China

Institute of Pharmacology and Toxicology Academy of Millitary Medical Sciences P.l.a. China

Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.l.a. China of Beijing

Hunan Nanxin Pharmaceutical Co., Ltd.

Zhibing Zheng

Song Li

Wu Zhong

Junhai Xiao

Xinbo Zhou

Lili Wang

Xingzhou Li

Yunde Xie

Xiaokui Wang

Guoming Zhao

Hongying Liu

Wei Li

Wei Chen

Hao Cui

Hongliang Wang

Long Long

Yanqun Zeng

Xin Li

Juan Liu

Xian Wei Zhang

Ruiyuan Cao

Guoliang Hu

Kunlun He

Chunlei Liu

Ruijun Li

Jie Tang

Jie Wang

Fei Xie

Chunsheng Gao

Meiyan Yang

Yuli Wang

Xuejun Zhu

Zehui Gong

Li Shan

Mingming Zhao

Chunlai Mi

Guangqiang Xia

Dian Xiao

Ying Wang

Yang Zhang

Cheng Xu

Gang Cheng

Yao Liu

Jing Yan Ma

Jing Su

Bing Zhang

Yanming Wang

Bing Li

Qi Sun

Ping Liu

Hongqiang Wang

Jie Bai

Dan Jiang

Dan Han

Feifei Li

Dalong Ma

Hui Qi

Mengjia Liu

Aihua Nie

Cuifang Lin

Chengmai Ruan

Jing Ma

Shuang Cao

Yanbo Yang

Guochao Liao

Xinghai Ma

Xiaoye Zhang

Libao Xu

Shiyong Fan

Fangyuan Cao

Boqun Lyu

Haoming Luo

Hongwei Gong

Xiaomei Ling

Meina Li

Enquan Xu

Kunluu He

Xiaoqian Xu

Hua Guan

Xian Zhang

The present application relates to a linker containing arylnitro, an antibody-drug conjugate the linker and use of the linker, as well as a pharmaceutical composition comprising the antibody-drug conjugate and use of the antibody-drug conjugate for treatment and/or prevention of a disease

Linker containing arylnitro, antibody-drug conjugate containing linker and use of linker

The present invention provides a compound of a general formula I, a stereomeride, pharmaceutically acceptable salt or a solvate thereof, a preparation method thereof, and usages in preparing medicines for preventing and/or treating diseases or symptoms caused by drug-resistant tumors or drug-resistant bacteria and in preparing medicines for preventing and/or treating diseases or symptoms related to tumors, neurodegenerative diseases, allogeneic transplantation rejection, and infection. Preferably, the diseases or symptoms related to tumors, neurodegenerative diseases, allogeneic transplantation rejection, and infection are diseases or symptoms caused by a heat shock protein 70 (Hsp70). The compound in the present invention is used for overcoming a difficult problem of drug resistance of tumors, improves the effect of tumor treatment, and provides a new medical strategy for clinical tumor treatment. 

Piperidine carboxamide compound, preparation method, and use thereof

The present invention pertains to field of pharmaceutical chemicals, and relates to thiazole inner salt compounds, preparation methods and uses thereof. Specifically, the present invention relates to a compound of Formula I, hydrates or pharmaceutically acceptable salts thereof. The compound of Formula I of the present invention is a potent cross-linking protein cleavage agent, has a stable structure, good physical and chemical properties, and good pharmacological activities, and is suitable for large scale production to obtain samples with stable, controllable and reliable quality, thereby being suitable for pharmaceutical development. 

Thiazole inner salt compounds, and preparation methods and uses thereof

Disclosed in the present invention is a compound of Formula (I), a geometric or optical isomer, a pharmaceutically acceptable salt, a solvate or a polymorph thereof. Also disclosed in the present invention is a composition comprising the compound of Formula (I), the geometric or optical isomer, the pharmaceutically acceptable salt, the solvate or the polymorph thereof. Also disclosed in the present invention is a use of the compound of Formula (I), the geometric or optical isomer, the pharmaceutically acceptable salt, the solvate or the polymorph thereof in the treatment of a disease or disorder such as a hypoglutamatergic condition, a neurodegenerative disease or respiratory depression, particularly in the treatment of a disease or disorder associated with AMPA receptor. 

Brain-targeting prodrug for AMPA receptor synergist, and pharmaceutical applications thereof

The present invention relates to a 2,3-epoxy succinyl derivative, a preparation method and a use thereof, in particular, the present invention relates to a compound represented by Formula (1), a racemate or an optical isomer thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof. The compound according to the present invention has good inhibitory activity and/or selectivity against cathepsin, especially Cathepsin B, can be used in the treatment of multiple diseases associated with cathepsin, for example, osteoporosis, rheumatoid arthritis and osteoarthritis that are associated with Cathepsin K, Ebola virus infection, a degenerative disease and an autoimmune disease that are associated with Cathepsin L, S, especially Cathepsin B-related tumor diseases, such as gastric cancer, cervical cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, colon cancer, neuroglioma, and melanoma. 

2,3-epoxy succinyl derivative, preparation method and use thereof

The present invention relates to a compound represented by Formula I, a racemate or optical isomer thereof, or a pharmaceutically acceptable salt, a solvate or a hydrate thereof, a pharmaceutical composition comprising the compound, and a use thereof in the manufacture of a medicament for preventing and/or treating a disease or disorder associated with a viral infection. 

4-oxo-4,5-dihydrothiazole derivative, preparation method and use thereof

The invention belongs to the technical field of medicines. In particular, the invention relates to a thiazideamide derivative compound or a pharmaceutically acceptable salt or solvate thereof, a pharmaceutical composition comprising the compound or a pharmaceutically acceptable salt or solvate thereof, a method for preparing the compound or a pharmaceutically acceptable salt or solvate thereof, and a use of the compound or a pharmaceutically acceptable salt or solvate thereof. For example, the compound or a pharmaceutically acceptable salt or solvate thereof according to the invention can be used to prevent and/or treat a neurodegenerative disease or a neuropathic disease caused by a physical trauma or a related disease.

Thiazideamide derivative and use thereof

The present invention pertains to the field of pharmaceutical chemicals, and relates to a substituted acethydrazide derivative, preparation method and use thereof; preferably, relates to a compound of Formula I or a pharmaceutically acceptable salt thereof. The compound of the present invention or a pharmaceutically acceptable salt thereof can effectively inhibit proline hydroxylase, stabilize HIF-&#x3b1;, particularly HIF-1&#x3b1;, and has potency in the manufacture of a medicament for treatment and/or prophylaxis and/or adjuvant therapy of anemia, acute ischemic reperfusion injury. 

Substituted acethydrazide derivative, preparation method and use thereof

The invention relates to tizoxanide phosphate or alkane sulfonate compounds represented by Formula I, and pharmaceutically acceptable salts thereof, isomers thereof, hydrates thereof or solvates thereof, and pharmaceutical applications of the compounds. 

Tizoxanide phosphate and alkane sulfonate and pharmaceutical applications thereof

The invention relates to a tizoxanide carbamate compound of Formula I and a pharmaceutically acceptable salt, a hydrate or a solvate thereof, and their pharmaceutical use. 

Tizoxanide carbamate and pharmaceutical use thereof

The invention relates to a homoserine lactone derivative of Formula I, preparation method and use thereof. The compound has an effect of regulatory of bacterial quorum sensing, and is useful for preventing and/or treating a disease caused by infection of a bacterium 

N-sulfonyl homoserine lactone derivatives, preparation method and use thereof

The present invention relates to a compound of formula (I), a stereomeride, pharmaceutically acceptable salt, a solvate or an N-oxide thereof, a medicine composition comprising the compound, a method for preparing the compound, and a usage of the compound in treating diseases related to Hsp70. The diseases are preferably selected from tumors, neurodegenerative diseases, and allogeneic transplantation rejection and infection. 

N,N' substituted piperidinamine compounds, and preparation method and usage thereof

The invention relates to a compound of formula I, and a preparation method and use thereof. The compound has a bacterial quorum-sensing regulatory effect, and can be used for prevention and/or treatment of a disease caused by a bacterial infection. 

Bacterial quorum sensing regulator and medical use thereof

Piperidine carboxamide compound, preparation method, and usage thereof

Growing community of inventors

Beijing, China

Zhibing Zheng